Buy Laringotab (pyridoxine, lysozyme)

Laringotab (pyridoxine, lysozyme)

Description

Features

Reviews

Instructions for Laringotab (pyridoxine, lysozyme)

ATX code:
R02AA20 (Other antiseptics)

Active substances
pyridoxine (pyridoxine) Rec.INN registered by WHO
lysozyme (lysozyme)

Drug form Laringotab
Table D/Suction 20 mg+10 mg: 10 or 30 pcs.

The form of release, packaging and composition of the drug Laryngotab
Suction tablets from white to almost white with a brown shade of color, round, double-convex; allowed droppings.

1 tab
lysozyme hydrochloride* 20 mg
pyridoxine hydrochloride 10 mg
* Lysozyme hydrochloride with nominal activity of 40000 FIP U/mg

Auxiliary substances:
hypromellose - 10 mg, povidone K-25 - 7.82 mg, magnesium stearate - 4 mg, sodium saccharinate - 0.4 mg, flavoring vanilla - 0.1 mg, lactose monohydrate - until the preparation of a tablet weighing 200 mg.

Clinical-pharmacological group:
Antiseptic for local use in ENT-practice and dentistry

Pharmacotherapeutic group:
Drugs for the treatment of throat disorders; antiseptics

"Pharmacological Action Laringotab

Laryngotab is a modern remedy that contains a combination of antiseptic components. Its main active substances, lysozyme and pyridoxine, have a number of useful properties.

Lysozyme is an enzyme of protein origin that acts directly on gram-positive and gram-negative bacteria, fungi, and viruses. Its antiseptic action makes it a good choice for fighting infection-inflammatory diseases of the mouth and larynx. Lysozyme is also involved in the regulation of local immunity, increasing its effectiveness.

Pyridoxine, in turn, protects the oral mucosa by preventing various ulcers and erosions. It has an antiaphthous effect, which is especially useful in the treatment of gingivitis, stomatitis and aphthous ulcers. It is important to note that pyridoxine does not affect the pharmacological properties of lysozyme, and therefore they are complementary components.

Indications for Laryngotab Laringotab

Laryngotab is recommended for the treatment of infectious-inflammatory diseases of the mouth, gums and larynx. Indications include gingivitis, stomatitis, upper respiratory tract catarrhal events, aphthous ulcerations and herpetic lesions of the oral mucosa (as part of complex therapy). Laryngotab can also be used to treat oral mucosal erosions of various etiologies.

Dosing and method of use Laringotab

Consult a doctor or follow the drug instructions to determine the best dosing regimen. Laryngotab is used topically in the mouth 3 to 4 times a day. A treatment course of 8 days is recommended.
Laryngotab is your reliable assistant in the fight against infectious and inflammatory diseases of the mouth and larynx. Due to its combination effect, the drug provides comprehensive protection and effective recovery of the mucous membrane."